Medyra Pharmaceutical — Sorafenib Exporter Profile
Indian Pharmaceutical Exporter · #3 for Sorafenib · $162.4K export value · DGFT Verified
Medyra Pharmaceutical is the #3 Indian exporter of Sorafenib with $162.4K in export value and 15 verified shipments. Medyra Pharmaceutical holds a 1.0% market share in Sorafenib exports across 4 countries.
Medyra Pharmaceutical — Sorafenib Export Profile: Buyers & Destinations
Where Does Medyra Pharmaceutical Export Sorafenib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AFGHANISTAN | $53.9K | 6 | 70.1% |
| CAMEROON | $22.5K | 7 | 29.3% |
| ZAMBIA | $252 | 1 | 0.3% |
| THAILAND | $157 | 1 | 0.2% |
Medyra Pharmaceutical exports Sorafenib to 4 countries. The largest destination is AFGHANISTAN accounting for 70.1% of Medyra Pharmaceutical's Sorafenib shipments, followed by CAMEROON (29.3%) and ZAMBIA (0.3%). These destinations reflect Medyra Pharmaceutical's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sorafenib from Medyra Pharmaceutical?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BY THE ORDER OF | CAMEROON | $52.4K | 4 |
| BY THE ORDER OF : | CAMEROON | $3.6K | 6 |
| BY THE ORDER OF MUHAMMAD WARES SAFAI CO | AFGHANISTAN | $929 | 1 |
| QAIS HOTAK LTD. | AFGHANISTAN | $311 | 1 |
| ANYE EPSE AYONGWA PRISCILLA | CAMEROON | $99 | 1 |
Medyra Pharmaceutical supplies Sorafenib to 5 buyers globally. The largest buyer is BY THE ORDER OF (CAMEROON), followed by BY THE ORDER OF : (CAMEROON) and BY THE ORDER OF MUHAMMAD WARES SAFAI CO (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sorafenib Export Value and How Much Does Medyra Pharmaceutical Contribute?
India exported $1.9M worth of Sorafenib through 916 shipments from 203 suppliers to 98 countries, serving 341 buyers globally. Medyra Pharmaceutical contributes $162.4K to this total, accounting for 1.0% of India's Sorafenib exports. Medyra Pharmaceutical ships Sorafenib to 4 countries through 5 buyers.
What Is the Average Shipment Value for Medyra Pharmaceutical's Sorafenib Exports?
Medyra Pharmaceutical's average Sorafenib shipment value is $10.8K per consignment, based on 15 shipments totaling $162.4K. The largest destination is AFGHANISTAN (70.1% of Medyra Pharmaceutical's Sorafenib exports).
How Does Medyra Pharmaceutical Compare to Other Indian Sorafenib Exporters?
Medyra Pharmaceutical ranks #3 among 203 Indian Sorafenib exporters with a 1.0% market share. The top 3 exporters are NATCO PHARMA LIMITED ($850.0K), TORRENT PHARMACEUTICALS LTD ($600.0K), MEDYRA PHARMACEUTICAL ($162.4K). Medyra Pharmaceutical processed 15 shipments to 4 destination countries.
What Sorafenib Formulations Does Medyra Pharmaceutical Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SORAFYRA-200 SORAFENIB 200MG TABLETS(1X30TABS,560BTL)(T23SF10A3 M.01-10-2023 E.30-09-2025) | $50.0K | 1 |
| SORAFYRA-200 SORAFENIB 200MG TABLETS1X30 TABS,480 BTLBATCH NO.T23SF08A1 M.01-08-2023 E.31-07-2025 | $19.4K | 2 |
| SORAFYRA-200 SORAFENIB 200MG TABS IP(100X30TABS)(BATCH NO.T23SF10A3,T25SF01A1) | $1.9K | 1 |
| SORAFYRA-200 SORAFENIB 200 MG TABS IP (T23SF10A3 M.01/10/2023 E.30/09/2025,T25SF01A1 M.01/01/25 E.31/12/26)(150X30TABS) | $941 | 1 |
| SORAFYRA-200 SORAFENIB 200MG TABLETS1X30TABS,100BOTTLEBATCH NO.T23SF08A1 M.01-08-2023 E.31-07-2025 | $929 | 1 |
| SORAFYRA-200 SORAFENIB 200MG TABLETS IP(1X30 TABS,100 BOTTLE)(T23SF10A3 M.01-10-2023 E.30-09-2025) | $842 | 1 |
| SORAFYRA-200 SORAFENIB 200MG TABLETS IP(1X30TAB,100 BTL)(T23SF08A1 M.1-8-23 E.31-7-25,T23SF10A3 M.01-10-23 E.30-09-25) | $833 | 1 |
| ADRITINIB SORAFENIB 200MG TAB.(1X30TAB., | $617 | 1 |
| SORABENZ-200 SORAFENIB 200MG TABLETS MFG | $518 | 2 |
| SORAFYRA-200 SORAFENIB 200 MG TABLETS IP(T24SF09A4 M.01/09/2024 E.31/08/2026)(30X50) | $311 | 1 |
Medyra Pharmaceutical exports 13 distinct Sorafenib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SORAFYRA-200 SORAFENIB 200MG TABLETS(1X30TABS,560BTL)(T23SF1 with 1 shipments worth $50.0K.
How Does Medyra Pharmaceutical Compare to Nearest Sorafenib Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | NATCO PHARMA LIMITED | $850.0K | 17 | 4 | $50.0K |
| 1 | TORRENT PHARMACEUTICALS LTD | $600.0K | 12 | 2 | $50.0K |
| 3 | MEDYRA PHARMACEUTICAL ★ | $162.4K | 15 | 4 | $10.8K |
| 4 | HEET HEALTHCARE PRIVATE LIMITED | $76.4K | 34 | 9 | $2.2K |
| 5 | JODAS EXPOIM PRIVATE LIMITED | $66.5K | 4 | 1 | $16.6K |
Medyra Pharmaceutical ranks #3 among 203 Indian Sorafenib exporters. Average shipment value of $10.8K compared to the market average of $9.3K. The closest competitors by value are NATCO PHARMA LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Sorafenib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 245 | 26.7% |
| SAHAR AIR | 197 | 21.5% |
| DELHI AIR CARGO ACC (INDEL4) | 89 | 9.7% |
| Bombay Air | 69 | 7.5% |
| DELHI AIR | 68 | 7.4% |
| AHEMDABAD AIR | 37 | 4.0% |
| Bombay Air Cargo | 27 | 2.9% |
| AHEMDABAD AIR ACC (INAMD4) | 20 | 2.2% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sorafenib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sorafenib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medyra Pharmaceutical matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching Medyra Pharmaceutical exporting Sorafenib, covering 13 formulations to 4 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 341+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sorafenib Export Data from Medyra Pharmaceutical
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medyra Pharmaceutical's Sorafenib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medyra Pharmaceutical
Company Profile
0 products · $0 total trade · 0 categories
Sorafenib Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medyra Pharmaceutical.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sorafenib. For current shipment-level data, contact TransData Nexus.